Workflow
BioXcel Therapeutics (NasdaqCM:BTAI) FY Conference Transcript

BioXcel Therapeutics (NasdaqCM:BTAI) FY Conference September 08, 2025 04:30 PM ET Company ParticipantsVimal Mehta - Co-Founder, CEO & DirectorEduardo Martinez-Montes - Biotechnology Equity Research AssociateEduardo Martinez-MontesGood afternoon, everyone, and thank you for joining us for another session of HC Wainwright's 27th Annual Global Investment Conference. My name is Eduardo Martinez, and I'm a Biotechnology Equity Research Associate at HC Wainwright. It is my pleasure to introduce Mr. Vimal Mehta, C ...